Výsledky vyhledávání - "Afsheen N. Iqbal"

Akademický článek

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma

Publikováno v: JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100440- (2023)

Introduction: Single-agent monoclonal antibody therapy against programmed death-ligand 1 (PD-L1) has modest effects in malignant pleural mesothelioma. Radiation therapy can enhance the antitumor effects of immunotherapy. Nevertheless, the safety of c

Externí odkaz: https://doaj.org/article/8350f1d8ba0d4d41ad97457d20805a67

Zobrazit plný text záznamu

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Autor: Arielle Elkrief, Alex Makhnin, Khadeja A. Moses, Linda S. Ahn, Isabel R. Preeshagul, Afsheen N. Iqbal, Sara A. Hayes, Andrew J. Plodkowski, Paul K. Paik, Marc Ladanyi, Mark G. Kris, Gregory J. Riely, Franziska Michor, Helena A. Yu

Publikováno v: Clinical Cancer Research. 29:1423-1428

Purpose: Primary and acquired resistance to osimertinib remain significant challenges for patients with EGFR-mutant lung cancers. Acquired EGFR alterations such as EGFR T790M or C797S mediate resistance to EGFR tyrosine kinase inhibitors (TKI) and co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54f4f625ed5f97d1b7e414751e5f95a4
https://doi.org/10.1158/1078-0432.ccr-22-3484

Zobrazit plný text záznamu

Supplemental Figure 1 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Autor: Helena A. Yu, Franziska Michor, Gregory J. Riely, Mark G. Kris, Marc Ladanyi, Paul K. Paik, Andrew J. Plodkowski, Sara A. Hayes, Afsheen N. Iqbal, Isabel R. Preeshagul, Linda S. Ahn, Khadeja A. Moses, Alex Makhnin, Arielle Elkrief

Supplemental Figure 1. Dose modifications of Combination Osimertinib and Dacomitinib (initial therapy study).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c64047c576307a4e9d5e188c4c469b
https://doi.org/10.1158/1078-0432.22632971.v1

Zobrazit plný text záznamu

Supplemental Figure 4 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Supplemental Figure 4. A. Median progression-free survival and B. Overall survival for patients enrolled in the acquired resistance study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d58e9d9523326d1f9db1fbe06b7815
https://doi.org/10.1158/1078-0432.22632962.v1

Zobrazit plný text záznamu

Supplemental Figure 3 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Supplemental Figure 3. A. Median progression-free survival and B. Overall survival for patients enrolled in the initial therapy study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1787c7367d2892ace2a1d49ed62c869c
https://doi.org/10.1158/1078-0432.22490464

Zobrazit plný text záznamu

Supplemental Figure 2 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Supplemental Figure 2. Dose modifications of Dacomitinib +/- Osimertinib (acquired resistance study).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e1611fe736d1bb322b395996ea6b5f
https://doi.org/10.1158/1078-0432.22490467

Zobrazit plný text záznamu

Supplementary Table 1 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

Supplemental Table 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9da03b1490517c4381387ca858292b
https://doi.org/10.1158/1078-0432.22490458

Zobrazit plný text záznamu

Persistent pain in anal cancer survivors

Autor: Victor T. Chang, Manzurul Sikder, Afsheen N Iqbal, Simon Badin

Publikováno v: Journal of Cancer Survivorship. 2:79-83

Anorectal cancers are highly curable malignancies. Combined modality treatment with chemotherapy and radiation has dramatically improved both disease-free and overall survival. Little is known about symptomatic complications of treatment.Case report

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f186a375e7714d752774bcf1f3014864
https://doi.org/10.1007/s11764-008-0051-4

Zobrazit plný text záznamu

Guillain-Barre Syndrome Complicating Multiple Myeloma

Autor: Rajeev Motiwala, Nikoletta Lendvai, Stuart L. Goldberg, Leila J Clay, David S. Siegel, Tej Motiwala, Afsheen N Iqbal, Quan Le

Publikováno v: Blood. 112:5135-5135

Background: Although neuropathies complicating multiple myeloma (MM) are common as a result of medications and spinal cord compression, neuropathy as a consequence of cross reactivity between the paraprotein and neural tissues is rare. In CANOMAD syn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::32555e1a6c266917924ceb9059a6442d
https://doi.org/10.1182/blood.v112.11.5135.5135

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání